Yu Li
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Temporal Heterogeneous in the Effectiveness of Inactivated CoronaVac and Sinopharm Vaccines Against SARS-CoV-2 Reinfections in China.
Journal: Transboundary and emerging diseases
Published: December 21, 2023
Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 to Close Contacts, China, January-February 2020.
Journal: Emerging infectious diseases
Published: August 23, 2021
SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients.
Journal: Cellular & molecular immunology
Published: June 06, 2021
Correction to: Risk factors for developing severe COVID-19 in China: an analysis of disease surveillance data.
Journal: Infectious diseases of poverty
Published: June 03, 2021
Estimating the Latent Period of Coronavirus Disease 2019 (COVID-19).
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 03, 2021
Assessing Asymptomatic, Presymptomatic, and Symptomatic Transmission Risk of Severe Acute Respiratory Syndrome Coronavirus 2.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 09, 2021
Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China.
Journal: The Lancet regional health. Western Pacific
Published: October 26, 2020
Evidence for pre-symptomatic transmission of coronavirus disease 2019 (COVID-19) in China.
Journal: Influenza and other respiratory viruses
Published: June 24, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026